Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in roche

Working To Increase Production Capacity Of Actemra: Roche

India saw a record single-day rise of 3,60,960 coronavirus cases, which pushed the total tally to 1,79,97,267, while the death toll crossed two lakh following 3,293 fresh fatalities.

Read More

Roche Buys GenMark For $1.8 Million To Challenge Test Rivals

The market for such tests in 2019 was $800 million annually, Roche diagnostics head Thomas Schinecker said, citing industry figures, adding it should grow by 20% annually to top $2 billion by 2024.

Read More

Roche Arthritis Drug Reduces COVID-19 Deaths In Trial In Hospitalised Patients

Actemra rose to become Roche's fifth-best-selling drug, at more than $3 billion, with nearly $600 million from COVID-19 treatment.

Read More

Roche Fourth-Quarter Sales Helped By COVID-19 Test Business

Sales were 58.3 billion francs, down 5% from 61.5 billion a year ago as the strong Swiss franc weighed on revenue but 1% higher at constant currency rates.

Read More

Roche Confirms 2020 Outlook As COVID-19 Diagnostics Surge

Sales of diagnostics including tests for the new coronavirus, of which Roche offers several to both detect active and past infections, rose 2% through September to 9.7 billion Swiss francs ($10.6 billion)

Read More

UK's COVID-19 Testing System Hit By Roche Supply Problems

Roche is one of the main suppliers of diagnostic tests to the National Health Service (NHS) Test and Trace programme, which has already suffered setbacks including a technical glitch that delayed the reporting of 15,000 positive results.

Read More

Roche Studies Ocrevus, Experimental Drug In MS As Novartis Moves In

Roche has started a late-stage clinical trial for its molecule fenebrutinib and is doing a clinical trial of higher-dose Ocrevus against relapsing MS and primary progressive MS.

Read More

Roche Receives US Emergency Approval For Coronavirus Vs. Flu Test

With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone.

Read More

Roche Bid To Retool Arthritis Drug For COVID-19 Fails

Pharmaceutical companies have been racing to develop treatments against the COVID-19 pandemic that has claimed nearly 660,000 lives and crippled economies.

Read More

Roche Maintains 2020 Outlook As Second-Quarter Sales Tumble On COVID-19 Hit

Second-quarter sales dropped 9.6% to 14.1 billion Swiss francs ($15.20 billion). Factoring out the strong Swiss franc, revenue fell 4%

Read More

EU Secures Potential COVID-19 Drugs From Roche, Germany's Merck

The medicine is also being tested on COVID-19 patients in combination with Gilead's antiviral remdesivir, the only drug so far authorised by the EU for use against COVID-19. Patients are still being recruited

Read More

EU Reaches Deals With Roche, Merck For Supply Of COVID-19 Drugs

The agreements follow requests from EU states in May to acquire the two drugs which are considered potentially useful against COVID-19.

Read More

Rising Swiss Rivalry As Roche And Novartis Target Same Diseases

Roche Chief Executive Severin Schwan is looking beyond cancer drugs to fresh treatment areas, while Novartis CEO Vas Narashiman bulks up in the same territory.

Read More

Roche Confirms 2020 Sales, Profit Outlook As Coronavirus Boosts Test Demand

Group sales in the first-quarter rose 7% to 15.1 billion Swiss francs ($15.57 billion), with drugs business revenue up 7% and diagnostics rising 5% at constant exchange rates.

Read More

Govt Issues Alert To Deter Use Of Roche's Avastin Drug For Eyes

Despite being a cancer drug, Avastin is often used by doctors globally for eye ailments even though it does not have US Food and Drug Administration approval for that purpose

Read More